To prohibit Federal interference with the interstate traffic of unpasteurized milk and milk products that are packaged for direct human consumption.

This bill directly addresses federal interference with the interstate traffic of unpasteurized milk and milk products. Currently, federal regulations, primarily under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, restrict the interstate sale of raw milk. HR7880 explicitly states that federal agencies cannot prohibit, interfere with, regulate, or restrict interstate traffic of unpasteurized milk if the prohibition is based solely on its unpasteurized status, and if both the state of origin and the destination state allow its distribution. This creates a clear legal pathway for raw milk producers in permissive states to access consumers in other permissive states, expanding their market reach. The money trail for this bill is not through direct appropriations or grants. Instead, it creates a regulatory relief mechanism that expands market access for existing raw milk producers and distributors. Companies involved in the production, packaging, and distribution of unpasteurized milk will see an increase in their total addressable market. This includes smaller, often local, dairy farms and specialized distributors. Since the bill focuses on unpasteurized milk, it primarily benefits niche agricultural producers and does not directly impact large-scale, publicly traded dairy corporations that predominantly deal in pasteurized products. Historically, federal regulations have largely restricted interstate raw milk sales. The FDA's stance has been consistent since the 1980s, effectively limiting raw milk sales to intrastate commerce. There is no direct historical precedent for federal legislation explicitly permitting interstate raw milk sales, making this a novel regulatory shift. The impact on publicly traded companies is expected to be minimal as the raw milk market is largely served by private entities and small farms. Therefore, no specific publicly traded tickers are directly impacted. Specific winners are small to medium-sized dairy farms and cooperatives that produce unpasteurized milk in states where its sale is already legal. These entities gain the ability to ship their products across state lines to consumers in other states where raw milk is permitted. There are no clear publicly traded losers, as the bill does not impose new restrictions or costs on pasteurized milk producers. The bill's passage would primarily benefit a niche segment of the agricultural sector. The next step is for the House Committee on Energy and Commerce to review the bill. If it passes committee, it would then move to a full House vote, followed by Senate consideration and presidential assent. This process typically takes months to years. No specific publicly traded companies are directly positioned to gain or lose significantly from this bill. The raw milk market is highly fragmented and predominantly served by private entities. Large dairy companies like $KHC (Kraft Heinz, owner of Breakstone's and Knudsen dairy products) or $SJM (J.M. Smucker, owner of Carnation milk) primarily deal in pasteurized products and are unlikely to be affected.